Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/4418
A61K-031/195
C07D-213/64
C07D-229/00
A61K-009/00
A61K-009/08
A61K-031/7056
A61K-047/12
A61K-047/18
A61K-031/714
A61K-047/10
출원번호
US-0485228
(2014-09-12)
등록번호
US-9415007
(2016-08-16)
발명자
/ 주소
Quay, Steven C.
Aprile, Peter C.
Go, Zenaida O.
Sileno, Anthony P.
출원인 / 주소
PAR PHARMACEUTICAL, INC.
대리인 / 주소
Arent Fox LLP
인용정보
피인용 횟수 :
0인용 특허 :
20
초록▼
A stable pharmaceutical mercury-free aqueous solution of cyanocobalamin comprised of cyanocobalamin and water wherein said solution of cyanocobalamin is suitable for intranasal administration, has a viscosity less than about 1000 cPs, and wherein said solution of cyanocobalamin has a bioavailability
A stable pharmaceutical mercury-free aqueous solution of cyanocobalamin comprised of cyanocobalamin and water wherein said solution of cyanocobalamin is suitable for intranasal administration, has a viscosity less than about 1000 cPs, and wherein said solution of cyanocobalamin has a bioavailability of cyanocobalamin when administered intranasally of at least about 7% relative to an intramuscular injection of cyanocobalamin with the proviso that the solution is essentially free of mercury and mercury-containing compounds. The present invention is also directed towards a method for elevating the vitamin B12 levels in the cerebral spinal fluid (CSF) comprising administering intranasally a sufficient amount of a mercury-free cyanocobalamin solution so as to increase the average ratio of vitamin B12 in the CSF to that in the blood serum (B12 CSF/B12 Serum×100) to at least about 1.1 comprising intranasally administering an aqueous solution of a cyanocobalamin, wherein said solution of cyanocobalamin has a bioavailability of at least 7% relative to an intramuscular injection of a cyanocobalamin.
대표청구항▼
1. A method for elevating a level of vitamin B12 in a subject having vitamin B12 deficiency associated with gastric surgery, comprising: administering an aqueous solution of cyanocobalamin to the subject having vitamin B12 deficiency associated with gastric surgery,wherein the aqueous solution of cy
1. A method for elevating a level of vitamin B12 in a subject having vitamin B12 deficiency associated with gastric surgery, comprising: administering an aqueous solution of cyanocobalamin to the subject having vitamin B12 deficiency associated with gastric surgery,wherein the aqueous solution of cyanocobalamin comprises: cyanocobalamin;water;a buffer selected from the group consisting of citric acid, sodium citrate, monopotassium phosphate, disodium phosphate, potassium biphthalate, sodium hydroxide, sodium acetate, acetic acid, and combinations thereof;optionally, a humectant selected from the group consisting of sorbitol, propylene glycol, and glycerin, and combinations thereof; andoptionally, a preservative selected from the group consisting of benzyl alcohol, parabens thimerosal, chlorobutanol, benzethonium chloride, and benzalkonium chloride, and combinations thereof;wherein the aqueous solution of cyanocobalamin is suitable for intranasal administration, has a viscosity of less than about 1000 cPs, and a bioavailability of cyanocobalamin when administered intranasally of at least about 7% relative to an intramuscular injection of cyanocobalamin. 2. The method of claim 1, wherein the cyanocobalamin is at a concentration of about 0.5% by total weight of solution. 3. The method of claim 1, wherein the buffer comprises citric acid at a concentration of about 0.12% by total weight of solution and sodium citrate at a concentration of about 0.32% by total weight of solution. 4. The method of claim 3, wherein the pH of the aqueous solution of cyanocobalamin is about 4 to about 6. 5. The method of claim 4, wherein the aqueous solution of cyanocobalamin contains a humectant. 6. The method of claim 5, wherein the humectant is glycerin at a concentration of about 2.23% by total weight of solution. 7. The method of claim 1, wherein the aqueous solution of cyanocobalamin contains a preservative. 8. The method of claim 7, wherein the preservative comprises chlorobutanol or benzalkonium chloride, or combinations thereof. 9. The method of claim 8, wherein the preservative is benzalkonium chloride at a concentration of about 0.02% by total weight of solution. 10. The method of claim 1, wherein the aqueous solution of cyanocobalamin contains no mercury or mercury-containing compounds. 11. The method of claim 1, wherein the aqueous solution of cyanocobalamin comprises: cyanocobalamin at a concentration of about 0.5% by total weight of the solution, citric acid at a concentration of about 0.12% by total weight of the solution, sodium citrate at a concentration of about 0.32% by total weight of the solution, glycerin at a concentration of about 2.23% by total weight of the solution, benzalkonium chloride at concentration of about 0.02% by total weight of the solution, and water. 12. The method of claim 1, wherein the aqueous solution of cyanocobalamin comprises: cyanocobalamin at a concentration of about 0.5% by total weight of the solution, citric acid at a concentration of about 0.12% by total weight of the solution, sodium citrate at a concentration of about 0.32% by total weight of the solution, glycerin at a concentration of about 2.23% by total weight of the solution, and water. 13. A method of using a kit for elevating a level of vitamin B12 in a subject having vitamin B12 deficiency associated with gastric surgery, the kit comprising: an aqueous solution of cyanocobalamin in a container; and an actuator coupled to the container, the actuator comprising a tip for producing a spray of the aqueous solution of cyanocobalamin when the actuator is engaged;the method comprising, administering the spray from the tip to a nose of a subject having vitamin B12 deficiency associated with gastric surgery,wherein the aqueous solution of cyanocobalamin comprises: cyanocobalamin;water;a buffer selected from the group consisting of citric acid, sodium citrate, monopotassium phosphate, disodium phosphate, potassium biphthalate, sodium hydroxide, sodium acetate, acetic acid, and combinations thereof;optionally, a humectant selected from the group consisting of sorbitol, propylene glycol, and glycerin, and combinations thereof; andoptionally, a preservative selected from the group consisting of benzyl alcohol, parabens thimerosal, chlorobutanol, benzethonium chloride, and benzalkonium chloride, and combinations thereof;wherein the aqueous solution of cyanocobalamin has a viscosity of less than about 1000 cPs and a bioavailability of cyanocobalamin when administered intranasally of at least about 7% relative to an intramuscular injection of cyanocobalamin. 14. The method of claim 13, wherein the spray has a spray pattern ellipticity ratio of about 1.0 to about 1.4 when measured at a height of 3.0 cm from the actuator tip. 15. The method of claim 13, wherein the spray comprises droplets, and wherein less than about 5% of the droplets are less than about 10 μm in size. 16. The method of claim 13, wherein the spray comprises droplets, and wherein less than about 50% of the droplets are less than about 26.9 μm in size. 17. The method of claim 13, wherein the spray has a spray pattern major axis and minor axis of about 25 to about 40 mm each. 18. The method of claim 13, wherein the cyanocobalamin is at a concentration of about 0.5% by total weight of solution. 19. The method of claim 13, wherein the aqueous solution of cyanocobalamin comprises: cyanocobalamin at a concentration of about 0.5% by total weight of the solution, citric acid at a concentration of about 0.12% by total weight of the solution, sodium citrate at a concentration of about 0.32% by total weight of the solution, glycerin at a concentration of about 2.23% by total weight of the solution, benzalkonium chloride at concentration of about 0.02% by total weight of the solution, and water. 20. The method of claim 13, wherein the aqueous solution of cyanocobalamin comprises: cyanocobalamin at a concentration of about 0.5% by total weight of the solution, citric acid at a concentration of about 0.12% by total weight of the solution, sodium citrate at a concentration of about 0.32% by total weight of the solution, glycerin at a concentration of about 2.23% by total weight of the solution, and water.
Esterberg Dennis R. ; Smith Mark A. ; Rubens Paul A. ; Lang Tracy A., Heat conductive substrate mounted in PC board for transferring heat from IC to heat sink.
Slocum Robert H. (Portola Valley CA) Lee Patrick L. Y. (Belmont CA) Arrizon-Lopez Vivian (San Jose CA), High resolution non corrosive amino acid analysis buffer solutions.
Hollister William H. (Nelson NH), Needle assembly holder with rotatable safety sheath member and method of effecting proper alignment of a cannula using s.
Baldridge, Jory R.; Johnson, David A.; Cluff, Christopher W., Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.